December 16, 2013 -
According to the company, the CAFC vacated previous judgement from the International Trade Commission that Suprema induced infringement by Mentalix of U.S. Patent No. 7,203,344, and also affirmed that the company did not infringe any of U.S. patent No. 7,277,562. According to the company, Cross Match advertises this patent as its “auto-capture” patent.
While the CAFC also affirmed the ITC’s previous ruling that Suprema’s Realscan-10 live scanner infringed Cross Match’s U.S. Patent No. 5,900,993, Suprema says its Realscan-10 had been discontinued years ago and replaced by its successor, the RealScan-G10.
BiometricUpdate.com has reached out to Cross Match for comment on this story, and an update will be provided.
As of yet patent infringement lawsuit activity has been minimal in the biometrics space, but this can be expected to heat up as adoption increases, and fights for market share intensify.